Estimating the attributable fraction for melanoma: A meta-analysis of pigmentary characteristics and freckling

International Journal of Cancer

Volumn 127, Issue 10, 2010, Pages 2430-2445

  Olsen, Catherine M ^a   Carroll, Heidi J ^a   Whiteman, David C ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

eye colour; freckling; hair colour; melanoma; skin phototype

Indexed keywords

ARTICLE; ATTRIBUTABLE RISK; CANCER PREVENTION; DISEASE ASSOCIATION; EYE COLOR; HAIR COLOR; HUMAN; LENTIGO; MEDICAL LITERATURE; MELANOMA; PRIORITY JOURNAL; PUBLISHING; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SKIN COLOR; SKIN PIGMENTATION; SYSTEMATIC REVIEW; CASE CONTROL STUDY; MELANOSIS; META ANALYSIS; PIGMENTATION; REVIEW;

CASE-CONTROL STUDIES; EYE COLOR; HAIR COLOR; HUMANS; MELANOMA; MELANOSIS; PIGMENTATION;

EID: 78049520359     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25243     Document Type: Article

References (97)

1. Walter SD,. The estimation and interpretation of attributable risk in health research. Biometrics 1976; 32: 829-49.
2. Olsen CM, Carroll HC, Whiteman DC,. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res 2010; 3: 233-45.
3. Olsen CM, Carroll HJ, Whiteman DC,. Familial melanoma: a meta-analysis and estimates of attributable fraction. Cancer Epidemiol Biomarkers Prev 2010; 19: 65-73.
4. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
5. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
6. Hardy RJ, Thompson SG,. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998; 17: 841-56.
7. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
8. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
9. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
10. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C,. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985; 122: 904-14.
11. Daly LE,. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 1998; 147: 783-90.
12. Cho E, Rosner BA, Feskanich D, Colditz GA,. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005; 23: 2669-75.
13. Veierod MB, Weiderpass E, Thorn M, Hansson J, Lund E, Armstrong B, Adami HO,. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003; 95: 1530-8.
14. Freedman DM, Sigurdson A, Rao RS, Hauptmann M, Alexander B, Mohan A, Morin Doody M, Linet MS,. Risk of melanoma among radiologic technologists in the United States. Int J Cancer 2003; 103: 556-62.
15. Han J, Colditz GA, Hunter DJ,. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol 2006; 35: 1514-21.
16. Le Marchand L, Saltzman BS, Hankin JH, Wilkens LR, Franke AA, Morris SJ, Kolonel LN,. Sun exposure, diet, and melanoma in Hawaii Caucasians. Am J Epidemiol 2006; 164: 232-45.
17. Titus-Ernstoff L, Perry AE, Spencer SK, Gibson JJ, Cole BF, Ernstoff MS,. Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer 2005; 116: 144-9.
18. Solomon CC, White E, Kristal AR, Vaughan T,. Melanoma and lifetime UV radiation. Cancer Causes Control 2004; 15: 893-902.
19. Shors AR, Solomon C, McTiernan A, White E,. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control 2001; 12: 599-606.
20. Langholz B, Richardson J, Rappaport E, Waisman J, Cockburn M, Mack T,. Skin characteristics and risk of superficial spreading and nodular melanoma (United States). Cancer Causes Control 2000; 11: 741-50.
21. Kolmel KF, Pfahlberg A, Mastrangelo G, Niin M, Botev IN, Seebacher C, Schneider D, Lambert D, Shafir R, Kokoschka EM, Kleeberg UR, Henz BM, et al. Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Res 1999; 9: 511-9.
22. Lock-Andersen J, Drzewiecki KT, Wulf HC,. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Acta Derm Venereol 1999; 79: 74-80.
23. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL,. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996; 88: 17-23.
24. Chen YT, Dubrow R, Holford TR, Zheng T, Barnhill RL, Fine J, Berwick M,. Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer 1996; 67: 636-43.
25. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N,. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995; 5: 59-65.
26. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ,. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 1995; 141: 934-42.
27. White E, Kirkpatrick CS, Lee JA,. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 1994; 139: 857-68.
28. Herzfeld PM, Fitzgerald EF, Hwang SA, Stark A,. A case-control study of malignant melanoma of the trunk among white males in upstate New York. Cancer Detect Prev 1993; 17: 601-8.
29. Marrett LD, King WD, Walter SD, From L,. Use of host factors to identify people at high risk for cutaneous malignant melanoma. CMAJ 1992; 147: 445-53.
30. Augustsson A, Stierner U, Rosdahl I, Suurkula M,. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol 1991; 71: 518-24.
31. Beitn er H, Norell SE, Ringborg U, Wennersten G, Mattson B,. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol 1990; 122: 43-51.
32. Osterlind A, Tucker MA, Hou-Jensen K, Stone BJ, Engholm G, Jensen OM,. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer 1988; 42: 200-6.
33. Green A, MacLennan R, Siskind V,. Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985; 35: 297-300.
34. Holman CD, Armstrong BK,. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72: 257-66.
35. Freedman DM, Zahm SH, Dosemeci M,. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 1997; 314: 1451-5.
36. Chiarugi A, Ceroti M, Palli D, Cevenini G, Guarrera M, Carli P,. Sensitivity to ultraviolet B is a risk factor for cutaneous melanoma in a Mediterranean population: results from an Italian case-control study. Clin Exp Dermatol 2009; 34: 8-15.
37. Hoiom V, Tuominen R, Kaller M, Linden D, Ahmadian A, Mansson-Brahme E, Egyhazi S, Sjoberg K, Lundeberg J, Hansson J,. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters. Pigment Cell Melanoma Res 2009; 22: 196-204.
38. Li C, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q,. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study. Int J Cancer 2008; 122: 2077-84.
39. Nikolaou VA, Sypsa V, Stefanaki I, Gogas H, Papadopoulos O, Polydorou D, Plaka M, Tsoutsos D, Dimou A, Mourtzoukou E, Korfitis V, Hatziolou E, et al. Risk associations of melanoma in a Southern European population: results of a case/control study. Cancer Causes Control 2008; 19: 671-9.
40. Fernandez L, Milne R, Bravo J, Lopez J, Aviles J, Longo M, Benitez J, Lazaro P, Ribas G,. MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis 2007; 28: 1659-64.
41. Fortes C, Mastroeni S, Melchi F, Pilla MA, Alotto M, Antonelli G, Camaione D, Bolli S, Luchetti E, Pasquini P,. The association between residential pesticide use and cutaneous melanoma. Eur J Cancer 2007; 43: 1066-75.
42. Mantzoros CS, Trakatelli M, Gogas H, Dessypris N, Stratigos A, Chrousos GP, Petridou ET,. Circulating adiponectin levels in relation to melanoma: a case-control study. Eur J Cancer 2007; 43: 1430-6.
43. Fears TR, Guerry Dt, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, Holly EA, Hartge P, Tucker MA,. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 2006; 24: 3590-6.
44. Zanetti R, Rosso S, Martinez C, Nieto A, Miranda A, Mercier M, Loria DI, Osterlind A, Greinert R, Navarro C, Fabbrocini G, Barbera C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer 2006; 94: 743-51.
45. Bataille V, Boniol M, De Vries E, Severi G, Brandberg Y, Sasieni P, Cuzick J, Eggermont A, Ringborg U, Grivegnee AR, Coebergh JW, Chignol MC, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005; 41: 2141-9.
46. Nijsten T, Leys C, Verbruggen K, Verlinden V, Drieghe J, Stas M, Lambert J, DeGreef H, Garmyn M,. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination. J Eur Acad Dermatol Venereol 2005; 19: 332-9.
47. Fargnoli MC, Piccolo D, Altobelli E, Formicone F, Chimenti S, Peris K,. Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study. Melanoma Res 2004; 14: 151-7.
48. Lasithiotakis K, Kruger-Krasagakis S, Ioannidou D, Pediaditis I, Tosca A,. Epidemiological differences for cutaneous melanoma in a relatively dark-skinned Caucasian population with chronic sun exposure. Eur J Cancer 2004; 40: 2502-7.
49. Ruiz Lascano A, Kuznitzky R, Cuestas E, Mainardi C, Albertini R, Borello A, Kurpis M, Campana R, Palazzo E,. [Risk factors for cutaneous melanoma: case-control study in Cordoba, Argentina]. Medicina (B Aires) 2004; 64: 504-8.
50. Wei Q, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Strom SS, Wang LE, Guo Z, Qiao Y, Amos CI, Spitz MR, Duvic M,. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 2003; 95: 308-15.
51. Bakos L, Wagner M, Bakos RM, Leite CS, Sperhacke CL, Dzekaniak KS, Gleisner AL,. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol 2002; 41: 557-62.
52. Kaskel P, Sander S, Kron M, Kind P, Peter RU, Krahn G,. Outdoor activities in childhood: a protective factor for cutaneous melanoma? Results of a case-control study in 271 matched pairs. Br J Dermatol 2001; 145: 602-9.
53. Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA, Landi G,. Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 2001; 85: 1304-10.
54. Loria D, Matos E,. Risk factors for cutaneous melanoma: a case-control study in Argentina. Int J Dermatol 2001; 40: 108-14.
55. Naldi L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C,. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer 2000; 88: 2703-10.
56. Carli P, Massi D, Santucci M, Biggeri A, Giannotti B,. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: Results from a case-control study. J Am Acad Dermtol 1999; 40: 549-57.
57. Tabenkin H, Tamir A, Sperber AD, Shapira M, Shvartzman P,. A case-control study of malignant melanoma in Israeli kibbutzim. Isr Med Assoc J 1999; 1: 154-7.
58. Wolf P, Quehenberger F, Mullegger R, Stranz B, Kerl H,. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study. Melanoma Res 1998; 8: 370-8.
59. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J,. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73: 1605-11.
60. Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, McCarthy WH,. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer 1996; 67: 485-91.
61. Rodenas JM, Delgado-Rodriguez M, Herranz MT, Tercedor J, Serrano S,. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control 1996; 7: 275-83.
62. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102: 695-9.
63. Zaridze D, Mukeria A, Duffy S,. Risk factors for skin melanoma in Moscow. Int J Cancer 1992; 52: 159-61.
64. Halpern AC, Guerry Dt, Elder DE, Clark WH, Jr., Synnestvedt M, Norman S, Ayerle R,. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol 1991; 127: 995-9.
65. Weiss J, Bertz J, Jung EG,. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes. Dermatologica 1991; 183: 109-13.
66. Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M,. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 1990; 19: 801-10.
67. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, Noe MC, Diconstanzo MP, Bonerandi JJ,. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66: 387-95.
68. Dubin N, Pasternack BS, Moseson M,. Simultaneous assessment of risk factors for malignant melanoma and non-melanoma skin lesions, with emphasis on sun exposure and related variables. Int J Epidemiol 1990; 19: 811-9.
69. Garbe C, Kruger S, Stadler R, Guggenmoos-Holzmann I, Orfanos CE,. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 1989; 28: 517-23.
70. MacKie RM, Freudenberger T, Aitchison TC,. Personal risk-factor chart for cutaneous melanoma. Lancet 1989; 2: 487-90.
71. Bell CM, Jenkinson CM, Murrells TJ, Skeet RG, Everall JD,. Aetiological factors in cutaneous malignant melanomas seen at a UK skin clinic. J Epidemiol Community Health 1987; 41: 306-11.
72. Cristofolini M, Franceschi S, Tasin L, Zumiani G, Piscioli F, Talamini R, La Vecchia C,. Risk factors for cutaneous malignant melanoma in a northern Italian population. Int J Cancer 1987; 39: 150-4.
73. Holly EA, Kelly JW, Shpall SN, Chiu SH,. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 459-68.
74. Elwood JM, Williamson C, Stapleton PJ,. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J Cancer 1986; 53: 65-74.
75. Beral V, Evans S, Shaw H, Milton G,. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983; 109: 165-72.
76. Lew RA, Sober AJ, Cook N, Marvell R, Fitzpatrick TB,. Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol 1983; 9: 981-6.
77. Klepp O, Magnus K,. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer 1979; 23: 482-6.
78. Hsieh CC, Walter SD,. The effect of non-differential exposure misclassification on estimates of the attributable and prevented fraction. Stat Med 1988; 7: 1073-85.
79. Rockhill B, Newman B, Weinberg C,. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-9.
80. Levine B, What does the population attributable fraction mean? Prev Chronic Dis 2007; 4: A14.
81. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, Boyle P, Melchi CF,. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 2040-59.
82. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA,. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66: 176-86.
83. Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2005; 97: 998-1007.
84. Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, Fargnoli MC,. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 2008; 122: 2753-60.
85. Duffy DL, Montgomery GW, Chen W, Zhao ZZ, Le L, James MR, Hayward NK, Martin NG, Sturm RA,. A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation. Am J Hum Genet 2007; 80: 241-52.
86. Jannot AS, Meziani R, Bertrand G, Gerard B, Descamps V, Archimbaud A, Picard C, Ollivaud L, Basset-Seguin N, Kerob D, Lanternier G, Lebbe C, et al. Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma. Eur J Hum Genet 2005; 13: 913-20.
87. Nan H, Kraft P, Hunter DJ, Han J,. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer 2009; 125: 909-17.
88. Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR, Hayward NK, Martin NG, Sturm RA,. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004; 13: 447-61.
89. Gudbjartsson DF, Sulem P, Stacey SN, Goldstein AM, Rafnar T, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Sveinsdottir SG, Magnusson V, Lindblom A, et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008; 40: 886-91.
90. Brown KM, Macgregor S, Montgomery GW, Craig DW, Zhao ZZ, Iyadurai K, Henders AK, Homer N, Campbell MJ, Stark M, Thomas S, Schmid H, et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 2008; 40: 838-40.
91. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Jakobsdottir M, Steinberg S, Gudjonsson SA, Palsson A, Thorleifsson G, Palsson S, Sigurgeirsson B, et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet 2008; 40: 835-7.
92. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 367-76.
93. Dwyer T, Stankovich JM, Blizzard L, FitzGerald LM, Dickinson JL, Reilly A, Williamson J, Ashbolt R, Berwick M, Sale MM,. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol 2004; 159: 826-33.
94. Han J, Kraft P, Colditz GA, Wong J, Hunter DJ,. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006; 119: 1976-84.
95. Olsen CM, Zens MS, Stukel TA, Sacerdote C, Chang YM, Armstrong BK, Bataille V, Berwick M, Elwood JM, Holly EA, Kirkpatrick C, Mack T, et al. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer 2009; 124: 937-44.
96. Veierod MB, Adami HO, Lund E, Armstrong BK, Weiderpass E,. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev 2010; 19: 111-20.
97. Dosemeci M, Hayes RB, Vetter R, Hoover RN, Tucker M, Engin K, Unsal M, Blair A,. Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control 1993; 4: 313-21.